108 related articles for article (PubMed ID: 8263137)
1. Subcutaneous administration of the amino-terminal fragment of human parathyroid hormone-(1-34): kinetics and biochemical response in estrogenized osteoporotic patients.
Lindsay R; Nieves J; Henneman E; Shen V; Cosman F
J Clin Endocrinol Metab; 1993 Dec; 77(6):1535-9. PubMed ID: 8263137
[TBL] [Abstract][Full Text] [Related]
2. Effects of conjugated estrogen on the calcitriol response to parathyroid hormone in postmenopausal women.
Marcus R; Villa ML; Cheema M; Cheema C; Newhall K; Holloway L
J Clin Endocrinol Metab; 1992 Feb; 74(2):413-8. PubMed ID: 1309837
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the pharmacokinetics of parenteral parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in healthy young humans.
Fraher LJ; Klein K; Marier R; Freeman D; Hendy GN; Goltzman D; Hodsman AB
J Clin Endocrinol Metab; 1995 Jan; 80(1):60-4. PubMed ID: 7829640
[TBL] [Abstract][Full Text] [Related]
4. Response of the parathyroid gland to infusion of human parathyroid hormone-(1-34) [PTH-(1-34)]: demonstration of suppression of endogenous secretion using immunoradiometric intact PTH-(1-84) assay.
Cosman F; Shen V; Herrington B; Lindsay R
J Clin Endocrinol Metab; 1991 Dec; 73(6):1345-51. PubMed ID: 1955517
[TBL] [Abstract][Full Text] [Related]
5. Interactions of growth hormone and parathyroid hormone in renal phosphate, calcium, and calcitriol metabolism and bone remodeling in postmenopausal women.
Lieberman SA; Holloway L; Marcus R; Hoffman AR
J Bone Miner Res; 1994 Nov; 9(11):1723-8. PubMed ID: 7863823
[TBL] [Abstract][Full Text] [Related]
6. Biochemical responses to sequential human parathyroid hormone (1-38) and calcitonin in osteoporotic patients.
Hodsman AB; Fraher LJ
Bone Miner; 1990 May; 9(2):137-52. PubMed ID: 2161692
[TBL] [Abstract][Full Text] [Related]
7. Renal 1,25-dihydroxyvitamin D, phosphaturic, and cyclic-AMP responses to intravenous synthetic human parathyroid hormone-(1-34) administration in normal subjects.
Slovik DM; Daly MA; Potts JT; Neer RM
Clin Endocrinol (Oxf); 1984 Apr; 20(4):369-75. PubMed ID: 6325049
[TBL] [Abstract][Full Text] [Related]
8. Effects of estrogen on response to edetic acid infusion in postmenopausal osteoporotic women.
Cosman F; Nieves J; Horton J; Shen V; Lindsay R
J Clin Endocrinol Metab; 1994 Apr; 78(4):939-43. PubMed ID: 8157725
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone (PTH)-related protein(1-36) is equipotent to PTH(1-34) in humans.
Everhart-Caye M; Inzucchi SE; Guinness-Henry J; Mitnick MA; Stewart AF
J Clin Endocrinol Metab; 1996 Jan; 81(1):199-208. PubMed ID: 8550752
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the in vivo biochemical responses to exogenous parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in man.
Fraher LJ; Hodsman AB; Jonas K; Saunders D; Rose CI; Henderson JE; Hendy GN; Goltzman D
J Clin Endocrinol Metab; 1992 Aug; 75(2):417-23. PubMed ID: 1322424
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
[TBL] [Abstract][Full Text] [Related]
12. Reduced parathyroid hormone response to peroral phosphate in osteoporotic patients.
Ittner J; Dambacher MA; Muff R; Rüegsegger P; Trechsel U; Fischer JA
Miner Electrolyte Metab; 1986; 12(3):199-203. PubMed ID: 3014300
[TBL] [Abstract][Full Text] [Related]
13. The effect of recombinant PTH(1-34) and PTH(1-84) on serum ionized calcium, 1,25-dihydroxyvitamin D, and urinary calcium excretion: a pilot study.
Piemonte S; Romagnoli E; Cipriani C; Fassino V; Del Fiacco R; Carnevale V; Scillitani A; D'Erasmo E; Tancredi A; Minisola S
Calcif Tissue Int; 2009 Oct; 85(4):287-92. PubMed ID: 19756348
[TBL] [Abstract][Full Text] [Related]
14. Single-dose subcutaneous administration of recombinant human parathyroid hormone [rhPTH(1-84)] in healthy postmenopausal volunteers.
Schwietert HR; Groen EW; Sollie FA; Jonkman JH
Clin Pharmacol Ther; 1997 Mar; 61(3):360-76. PubMed ID: 9084461
[TBL] [Abstract][Full Text] [Related]
15. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
[TBL] [Abstract][Full Text] [Related]
16. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
[TBL] [Abstract][Full Text] [Related]
17. Dissociation of bone formation from resorption during 2-week treatment with human parathyroid hormone-related peptide-(1-36) in humans: potential as an anabolic therapy for osteoporosis.
Plotkin H; Gundberg C; Mitnick M; Stewart AF
J Clin Endocrinol Metab; 1998 Aug; 83(8):2786-91. PubMed ID: 9709948
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
Hodsman AB; Fraher LJ; Watson PH; Ostbye T; Stitt LW; Adachi JD; Taves DH; Drost D
J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265
[TBL] [Abstract][Full Text] [Related]
19. Alendronate does not block the anabolic effect of PTH in postmenopausal osteoporotic women.
Cosman F; Nieves J; Woelfert L; Shen V; Lindsay R
J Bone Miner Res; 1998 Jun; 13(6):1051-5. PubMed ID: 9626638
[TBL] [Abstract][Full Text] [Related]
20. Effects of aluminum hydroxide on the parathyroid-vitamin D axis of postmenopausal women.
Villa ML; Packer E; Cheema M; Holloway L; Marcus R
J Clin Endocrinol Metab; 1991 Dec; 73(6):1256-61. PubMed ID: 1955506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
